Orca Bio
Developer of cell therapy products designed to safely replace patients' diseased blood and immune system with a healthy
Drug Discovery
📍 Menlo Park, CA
Founded 2015
Current Valuation
$1.2B
as of 2020-Q2
UNICORN
Developer of cell therapy products designed to safely replace patients' diseased blood and immune system with a healthy one.
Company Profile
Last Round
Series D — $192M (Jun 2020)
Fundraising Status
Series D · $192M · 6y ago
privateTotal raised $325M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series D | $192M | Jun 2020 | — | $1.2B |
Health CareMedicalPharmaceutical
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2020-Q2. Refreshed quarterly.